On April 25, 2017, (Proposed dates TBC) the US-Algeria Business Council, and PhRMA members, will convene the ALGERIA 2020 Leadership Committee Meeting in Algiers, Algeria, with executives from the Algerian Ministry of Health. This meeting will be a follow-up strategy session to the signing of the ALGERIA 2020 Memorandum of Understanding between the National Drug Testing Laboratory and PhRMA at the 2014 BIO International Convention in San Diego. The ALGERIA 2020 Leadership Committee designated three working groups with specific avenues of activity to implement significant upgrades in the healthcare system in Algeria. The three avenues are: Educational & Training Exchanges, Regulatory Harmonization and Drug Development & Manufacturing.